Taking into account the standard deviation of the price estimate, the stock could hit a price target of $54 on the low end and $95 on the high end, according to the report.
AmSurg has a market cap of $3.94 billion.
More articles on transactions and valuation issues:
AmSurg shares increase nearly 15%: 4 key points
MFC posts quarterly earnings
Surgery Partners files for IPO: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.